Global Companion Animal Vaccines Market Size & Outlook

The global companion animal vaccines market size was estimated at USD 3,946.9 million in 2024 and is projected to reach USD 6,274.3 million by 2030, growing at a CAGR of 8.3% from 2025 to 2030.
Revenue, 2024 (US$M)
$3,946.9
Forecast, 2030 (US$M)
$6,274.3
CAGR, 2025 - 2030
8.3%
Report Coverage
Worldwide

Global companion animal vaccines market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global companion animal vaccines market highlights

  • The global companion animal vaccines market generated a revenue of USD 3,946.9 million in 2024 and is expected to reach USD 6,274.3 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 8.3% by 2030.
  • In terms of segment, attenuated live vaccines accounted for a revenue of USD 1,585.9 million in 2024.
  • Inactivated Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 3,946.9 million
Market revenue in 2030USD 6,274.3 million
Growth rate8.3% (CAGR from 2025 to 2030)
Largest segmentAttenuated live vaccines
Fastest growing segmentInactivated Vaccines
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAttenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines

Other key industry trends

  • In terms of revenue, the North America accounted for 29.0% of the global companion animal vaccines market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, India is the fastest growing regional market and is projected to reach USD 345.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Companion Animal Vaccines Market Companies

Name Profile # Employees HQ Website
Calier View profile 101-250 Barcelona, Catalonia, Spain, Europe https://www.calier.com/espana/es-es
Bimeda View profile 1001-5000 Dublin, Dublin, Ireland, Europe https://www.bimeda.com/
Phibro Animal Health Corp Class A View profile 1920 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 https://www.pahc.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Neogen Corp View profile 2640 620 Lesher Place, Lansing, MI, United States, 48912 https://www.neogen.com
Elanco Animal Health Inc View profile 9800 2500 Innovation Way, Greenfield, IN, United States, 46140 https://www.elanco.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
CEVA Inc View profile 424 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 https://www.ceva-dsp.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Global companion animal vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal vaccines market will help companies and investors design strategic landscapes.


Attenuated live vaccines was the largest segment with a revenue share of 40.18% in 2024. Horizon Databook has segmented the Global companion animal vaccines market based on attenuated live vaccines, inactivated vaccines, subunit vaccines, dna vaccines, recombinant vaccines covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Companion Animal Vaccines Product Outlook (Revenue, USD Million, 2018-2030)
    • Attenuated Live Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • DNA Vaccines
    • Recombinant Vaccines
  • Global Companion Animal Vaccines Type Outlook (Revenue, USD Million, 2018-2030)
    • Canine
    • Feline
    • Others
  • Global Companion Animal Vaccines Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Subcutaneous
    • Intramuscular
    • Intranasal
  • Global Companion Animal Vaccines Distribution Outlook (Revenue, USD Million, 2018-2030)
    • Retail
    • E-Commerce
    • Hospital/ Clinic Pharmacy

Reasons to subscribe to Global companion animal vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global companion animal vaccines market databook

  • Our clientele includes a mix of companion animal vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global companion animal vaccines market , including forecasts for subscribers. This global databook contains high-level insights into Global companion animal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global companion animal vaccines market size, by regions, 2018-2030 (US$M)

Top 10 countries: Companion animal vaccines market size, 2024 (US$M)

Global companion animal vaccines market share, by product, 2024 & 2030 (%, US$M)

Companion animal vaccines market: Opportunity assessment by country

Global companion animal vaccines market, by region, 2024 (US$M)

Global companion animal vaccines market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online